In the News
Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements
On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional collaboration, among others. These changes are the...
Komodo Health Unveils New Annual Report Illuminating the State of Data Mining in Life Sciences
In a new survey, Komodo Health benchmarked the state of real-world data (RWD) and analytics. The survey, which is the first of its kind, explores the complexities of generating meaningful insights and the challenges life sciences teams face in making forward progress. RWD offers seemingly boundless potential, but...
PM360 Announces the Selections for its 12th Annual Innovations Issue
On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of areas, including Artificial Intelligence, Clinical...
ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform
Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple myeloma using data from Aster Avatar, including a...
New Study Shows Point-of-care Genetics May Improve Uptake, Reduce Racial Disparities
On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This study aims to identify which racial and ethnic...
Komodo Health Adds 90M Closed Lives Per Year To Expansive Healthcare Map
On Thursday, December 7th, medical technology company Komodo Health announced that it has expanded its Healthcare Map to include 90 million new closed patient lives annually, as a result of new partnerships it has made with third parties. This includes patients from Medicare, Medicaid, and commercial plans, among...
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
Telemedicine company Hims & Hers announced the launch of its new weight loss service, “Weight Loss by Hims & Hers,” in a press release on Monday, December 4, 2023. The new service aims to establish itself as a holistic alternative to traditional weight loss strategies, emphasizing users’ individual goals,...
Anthem BCBS Virginia, Aledade ink partnership
Aledade, Inc. has partnered with Anthem Blue Cross and Blue Shield to bring primary care to over 150,000 Medicare members across the Commonwealth of Virginia. The partnership was announced in a press release last week and signifies Aledade’s continued dedication to its mission of providing value-based care for all. ...
Aledade and Anthem Announce New Medicaid Partnership to Bring the Benefits of Value-Based Care to More Virginians
On Thursday, November 30, 2023, Aledade Inc. announced that it has partnered with Anthem Blue Cross and Blue Shield to increase quality and ease of access for patient care to people throughout the Commonwealth of Virginia. The initiative will provide improved and more accessible healthcare to more than 150,000...
Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform
Densitas Inc, an artificial intelligence and technology company, announced on Sunday that it has partnered with the cancer prevention service CancerIQ to include Cancer IQ’s Tyrer-Cuzick Version 8 risk calculator in its breast cancer screening offerings. This 8th version, released in March of 2018, uses...
Press Releases
Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy
On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...
Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements
On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional...
PM360 Announces the Selections for its 12th Annual Innovations Issue
On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of...
ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform
Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple...
New Study Shows Point-of-care Genetics May Improve Uptake, Reduce Racial Disparities
On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...